Evidence map›Paper›PMID 24586163›Full record

ArticlePLoS pathogens2014

Clonal expansion during Staphylococcus aureus infection dynamics reveals the effect of antibiotic intervention.

Gareth McVicker, Tomasz K Prajsnar, Alexander Williams, Nelly L Wagner, Michael Boots, Stephen A Renshaw, Simon J Foster

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Core Perturbomes ofPathogens (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Two codependent routes lead to high-level MRSA.Science (New York, N.Y.) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Bioactive metabolites ofFrontiers in cellular and infection microbiology · 2023
    Article
  14. Article
  15. NO-StressedInfection and immunity · 2022
    Article
  16. Article
  17. Article
  18. Investigating Pathogenicity and Virulence ofInternational journal of molecular sciences · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Gareth McVickerKrebs Institute, University of Sheffield, Western Bank, Sheffield, United Kingdom ; Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield, United Kingdom.
Tomasz K PrajsnarKrebs Institute, University of Sheffield, Western Bank, Sheffield, United Kingdom ; Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield, United Kingdom ; MRC Centre for Developmental and Biomedical Genetics, University of Sheffield, Western Bank, Sheffield, United Kingdom.
Alexander WilliamsKrebs Institute, University of Sheffield, Western Bank, Sheffield, United Kingdom ; Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield, United Kingdom ; MRC Centre for Developmental and Biomedical Genetics, University of Sheffield, Western Bank, Sheffield, United Kingdom.
Nelly L WagnerKrebs Institute, University of Sheffield, Western Bank, Sheffield, United Kingdom ; Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield, United Kingdom ; Department of Infection and Immunity, University of Sheffield, Western Bank, Sheffield, United Kingdom.
Michael BootsBiosciences, University of Exeter, Cornwall Campus, Penryn, United Kingdom.
Stephen A RenshawKrebs Institute, University of Sheffield, Western Bank, Sheffield, United Kingdom ; MRC Centre for Developmental and Biomedical Genetics, University of Sheffield, Western Bank, Sheffield, United Kingdom ; Department of Infection and Immunity, University of Sheffield, Western Bank, Sheffield, United Kingdom.
Simon J FosterKrebs Institute, University of Sheffield, Western Bank, Sheffield, United Kingdom ; Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield, United Kingdom.
University of Sheffield · GBUniversity of Exeter · GB

Funding

Medical Research Council G0700091Medical Research Council G0701932Medical Research Council G108/595Wellcome TrustWellcome Trust WT089981MA
6 · The paper itself

Abstract

To slow the inexorable rise of antibiotic resistance we must understand how drugs impact on pathogenesis and influence the selection of resistant clones. Staphylococcus aureus is an important human pathogen with populations of antibiotic-resistant bacteria in hospitals and the community. Host phagocytes play a crucial role in controlling S. aureus infection, which can lead to a population "bottleneck" whereby clonal expansion of a small fraction of the initial inoculum founds a systemic infection. Such population dynamics may have important consequences on the effect of antibiotic intervention. Low doses of antibiotics have been shown to affect in vitro growth and the generation of resistant mutants over the long term, however whether this has any in vivo relevance is unknown. In this work, the population dynamics of S. aureus pathogenesis were studied in vivo using antibiotic-resistant strains constructed in an isogenic background, coupled with systemic models of infection in both the mouse and zebrafish embryo. Murine experiments revealed unexpected and complex bacterial population kinetics arising from clonal expansion during infection in particular organs. We subsequently elucidated the effect of antibiotic intervention within the host using mixed inocula of resistant and sensitive bacteria. Sub-curative tetracycline doses support the preferential expansion of resistant microorganisms, importantly unrelated to effects on growth rate or de novo resistance acquisition. This novel phenomenon is generic, occurring with methicillin-resistant S. aureus (MRSA) in the presence of β-lactams and with the unrelated human pathogen Pseudomonas aeruginosa. The selection of resistant clones at low antibiotic levels can result in a rapid increase in their prevalence under conditions that would previously not be thought to favor them. Our results have key implications for the design of effective treatment regimes to limit the spread of antimicrobial resistance, where inappropriate usage leading to resistance may reduce the efficacy of life-saving drugs.

Indexed as

AnimalsAnti-Bacterial AgentsClone CellsDisease Models, AnimalDrug Resistance, MicrobialFemaleMiceMice, Inbred BALB CPopulation DynamicsStaphylococcal InfectionsStaphylococcus aureusZebrafishAnti-Bacterial Agents

Identifiers

PMID24586163
PMCPMC3937288
OpenAlexW1964206937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.